Holder evidence
50
SEC ownership of Insight Molecular Diagnostics Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001642380.
Lead holder
BROADWOOD PARTNERS, L.P.
13D/G signal
BROADWOOD PARTNERS, L.P.
Latest evidence
23 Apr 2026
- CIK
- 0001642380
- Symbol
- IMDX on Nasdaq
- Location
- Nashville, TN
- SEC evidence mix
- 3/4/5, 13D/G, and 13F
- Lead holder
- BROADWOOD PARTNERS, L.P.
- Latest large-stake holder
- BROADWOOD PARTNERS, L.P.
- Latest evidence date
- 23 Apr 2026
Issuer identity
Ownership snapshot
Ownership snapshot
Top shareholders of Insight Molecular Diagnostics Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
BROADWOOD PARTNERS, L.P.
13D/G signal
BROADWOOD PARTNERS, L.P.
Evidence rows
50
Latest as of
23 Apr 2026
3/4/5
13D/G
13F
Lead comparable stake: 40%
13D/G row: BROADWOOD PARTNERS, L.P.
Showing 1-8 of 50 holder rows.
Rank 1 holder
BROADWOOD PARTNERS, L.P.
3/4/5
13D/G
- Ownership
- 40%
- Position
- $88.48M
Rank 2 holder
Patrick W. Smith
3/4/5
13D/G
- Ownership
- 10%
- Position
- $6.68M
Rank 3 holder
AWM Investment Company, Inc.
13D/G
13F
- Ownership
- 10%
- Position
- $9.69M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BROADWOOD PARTNERS, L.P. |
3/4/5
13D/G
10%+ Owner · Neal C. Bradsher
|
40%
from 13D/G
|
$88,478,605
25,669,954 shares
mixed-class rows
|
+$5,685,126 | 23 Apr 2026 |
| Patrick W. Smith |
3/4/5
13D/G
10%+ Owner
|
10%
from 13D/G
|
$6,679,894
3,258,485 shares
|
— | 07 Feb 2025 |
| AWM Investment Company, Inc. |
13D/G
13F
Company
|
10%
|
$9,685,464
2,857,069 shares
|
+$5,257,076 | 31 Mar 2025 |
| BIO-RAD LABORATORIES, INC. |
13D/G
|
9.7%
|
$608,097
2,764,078 shares
|
$0 | 10 Feb 2025 |
| BROADWOOD CAPITAL INC |
3/4/5
13F
10%+ Owner · Company
|
37%
from 13F
|
$88,478,605
25,669,954 shares
mixed-class rows
|
+$2,685,127 | 23 Apr 2026 |
| PURA VIDA INVESTMENTS, LLC |
13F
3/4/5
Company · 10%+ Owner
|
2.9%
|
$3,106,600
947,134 shares
|
— | 31 Mar 2026 |
| Alyeska Investment Group, L.P. |
13F
Company
|
2.6%
|
$2,757,749
840,777 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
1.7%
|
$1,761,888
537,161 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$11,055,380.
Buys
$11,055,380
Insiders: 3
Sells
$0
Insiders: 0
Net
+$11,055,380
Shares: +2,780,874
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 2,780,874
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 2,259,135 | 0 | $8,055,381 | $0 | +$8,055,381 |
| 3-6 | 521,739 | 0 | $2,999,999 | $0 | +$2,999,999 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 23 reporting-owner rows connected to Insight Molecular Diagnostics Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
23
Lead holder
BROADWOOD CAPITAL INC
Net 12M change
+$11,055,380
Latest report
23 Apr 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC | 10%+ Owner | $88,478,605 | +$2,685,127 | +3.1% | Mixed | 23 Apr 2026 |
| BROADWOOD PARTNERS, L.P. | 10%+ Owner | $88,478,605 | +$5,685,126 | +6.9% | Mixed | 23 Apr 2026 |
| Neal C. Bradsher | 10%+ Owner | $88,478,605 | +$2,685,127 | +3.1% | Mixed | 23 Apr 2026 |
| Patrick W. Smith | 10%+ Owner | $6,679,894 | Mixed | 07 Feb 2025 | ||
| PURA VIDA INVESTMENTS, LLC | 10%+ Owner | $3,044,309 | Mixed | 14 Apr 2023 | ||
| Andrea S. James | Chief Financial Officer | $1,777,524 | Mixed | 26 Mar 2026 | ||
| Josh Riggs | CEO and President, Director | $674,529 | Mixed | 26 Mar 2026 | ||
| Andrew Arno | Director | $381,104 | Mixed | 01 Jul 2025 | ||
| John Peter Gutfreund | Former Director | $153,654 | Mixed | 30 Jun 2023 | ||
| Ronald Asbury Andrews | Former CEO, Director | $125,332 | Mixed | 01 Dec 2022 | ||
| Alfred D. Kingsley | Director | $109,143 | Mixed | 23 Jun 2023 | ||
| Andrew J. Last | Director | $104,303 | Mixed | 01 Jul 2025 | ||
| Lou Silverman | Director | $96,528 | Mixed | 01 Jul 2025 | ||
| Gisela Paulsen | Former President and COO | $78,761 | Mixed | 16 Dec 2022 | ||
| Li Yu | VP Cntrllr/Prncpl Acctng Offcr | $76,536 | Mixed | 18 May 2022 | ||
| James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | $66,509 | Mixed | 26 Mar 2026 | ||
| Ross Douglas T. | Former CSO | $50,311 | Mixed | 21 Dec 2022 | ||
| Cavan M. Redmond | Director | $25,973 | Mixed | 24 Jun 2022 | ||
| Mitchell S. Levine | Chief Financial Officer | $18,713 | Mixed | 15 Mar 2022 | ||
| Jennifer Levin Carter | Director | $6,554 | Mixed | 15 Aug 2022 |
Recent insider transactions for Insight Molecular Diagnostics Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Reported value | Reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| BROADWOOD PARTNERS, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,684,884 | 27 Apr 2026 | Footnote | |||
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,684,884 | 27 Apr 2026 | Footnote | |||
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,684,884 | 27 Apr 2026 | Footnote | |||
| BROADWOOD PARTNERS, L.P. | IMDX | Common Stock, no par value | Purchase | 2.02% | $913,134 | $3.64 | 250,923 | 12,684,884 | 27 Apr 2026 | Direct |
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 2.02% | $913,134 | $3.64 | 250,923 | 12,684,884 | 27 Apr 2026 | Direct |
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 2.02% | $913,134 | $3.64 | 250,923 | 12,684,884 | 27 Apr 2026 | Direct |
| BROADWOOD PARTNERS, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,433,961 | 24 Apr 2026 | Footnote | |||
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,433,961 | 24 Apr 2026 | Footnote | |||
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,433,961 | 24 Apr 2026 | Footnote | |||
| BROADWOOD PARTNERS, L.P. | IMDX | Common Stock, no par value | Purchase | 0.31% | $137,083 | $3.53 | 38,880 | 12,433,961 | 24 Apr 2026 | Direct |
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0.31% | $137,083 | $3.53 | 38,880 | 12,433,961 | 24 Apr 2026 | Direct |
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0.31% | $137,083 | $3.53 | 38,880 | 12,433,961 | 24 Apr 2026 | Direct |
| BROADWOOD PARTNERS, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,395,081 | 23 Apr 2026 | Footnote | |||
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,395,081 | 23 Apr 2026 | Footnote | |||
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,395,081 | 23 Apr 2026 | Footnote | |||
| BROADWOOD PARTNERS, L.P. | IMDX | Common Stock, no par value | Purchase | 2.31% | $982,034 | $3.50 | 280,381 | 12,395,081 | 23 Apr 2026 | Direct |
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 2.31% | $982,034 | $3.50 | 280,381 | 12,395,081 | 23 Apr 2026 | Direct |
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 2.31% | $982,034 | $3.50 | 280,381 | 12,395,081 | 23 Apr 2026 | Direct |
| BROADWOOD PARTNERS, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,114,700 | 20 Apr 2026 | Footnote | |||
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,114,700 | 20 Apr 2026 | Footnote | |||
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,114,700 | 20 Apr 2026 | Footnote | |||
| BROADWOOD PARTNERS, L.P. | IMDX | Common Stock, no par value | Purchase | 0.34% | $157,967 | $3.88 | 40,690 | 12,114,700 | 20 Apr 2026 | Direct |
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0.34% | $157,967 | $3.88 | 40,690 | 12,114,700 | 20 Apr 2026 | Direct |
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0.34% | $157,967 | $3.88 | 40,690 | 12,114,700 | 20 Apr 2026 | Direct |
| BROADWOOD PARTNERS, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,074,010 | 17 Apr 2026 | Footnote | |||
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,074,010 | 17 Apr 2026 | Footnote | |||
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,074,010 | 17 Apr 2026 | Footnote | |||
| BROADWOOD PARTNERS, L.P. | IMDX | Common Stock, no par value | Purchase | 0.33% | $143,251 | $3.57 | 40,114 | 12,074,010 | 17 Apr 2026 | Direct |
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0.33% | $143,251 | $3.57 | 40,114 | 12,074,010 | 17 Apr 2026 | Direct |
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0.33% | $143,251 | $3.57 | 40,114 | 12,074,010 | 17 Apr 2026 | Direct |
| BROADWOOD PARTNERS, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,033,896 | 16 Apr 2026 | Footnote | |||
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,033,896 | 16 Apr 2026 | Footnote | |||
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 12,033,896 | 16 Apr 2026 | Footnote | |||
| BROADWOOD PARTNERS, L.P. | IMDX | Common Stock, no par value | Purchase | 0.86% | $351,658 | $3.45 | 102,057 | 12,033,896 | 16 Apr 2026 | Direct |
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0.86% | $351,658 | $3.45 | 102,057 | 12,033,896 | 16 Apr 2026 | Direct |
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0.86% | $351,658 | $3.45 | 102,057 | 12,033,896 | 16 Apr 2026 | Direct |
| Andrea S. James | IMDX | Common Stock | Tax liability | -5.2% | -11,298 | 206,060 | 26 Mar 2026 | Direct | ||
| Andrea S. James | IMDX | Common Stock | Options Exercise | 15% | 28,302 | 217,358 | 26 Mar 2026 | Direct | ||
| Andrea S. James | IMDX | Restricted Stock Units | Options Exercise | -25% | -28,302 | 84,905 | 26 Mar 2026 | Direct | ||
| James Yang Liu | IMDX | Common Stock | Tax liability | -41% | -2,578 | 3,711 | 26 Mar 2026 | Direct | ||
| James Yang Liu | IMDX | Common Stock | Options Exercise | 6,289 | 6,289 | 26 Mar 2026 | Direct | |||
| James Yang Liu | IMDX | Restricted Stock Units | Options Exercise | -33.3% | -6,289 | 12,578 | 26 Mar 2026 | Direct | ||
| Josh Riggs | IMDX | Common Stock | Tax liability | -24.3% | -12,310 | 38,365 | 26 Mar 2026 | Direct | ||
| Josh Riggs | IMDX | Common Stock | Options Exercise | 1345.8% | 47,170 | 50,675 | 26 Mar 2026 | Direct | ||
| Josh Riggs | IMDX | Restricted Stock Units | Options Exercise | -25% | -47,170 | 141,509 | 26 Mar 2026 | Direct | ||
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 0 | 11,931,839 | 10 Feb 2026 | Footnote | |||
| Broadwood Partners, L.P. | IMDX | Common Stock, no par value | Purchase | 4.57% | $2,999,999 | $5.75 | 521,739 | 11,931,839 | 10 Feb 2026 | Direct |
| Andrea S. James | OCX | Common Stock | Tax liability | -6.05% | -12,175 | 189,056 | 31 Oct 2025 | Direct | ||
| Andrea S. James | OCX | Common Stock | Options Exercise | 33.1% | 50,000 | 201,231 | 31 Oct 2025 | Direct | ||
| Andrea S. James | OCX | Restricted Stock Units | Options Exercise | -50% | -50,000 | 50,000 | 31 Oct 2025 | Direct |
* indicates a reported price that failed the local validity check.